Related Experiment Video
Updated: Apr 20, 2026

Engineering Cell-permeable Protein
Published on: December 28, 2009
Engineering PTEN function: membrane association and activity
Jr-Ming Yang1, Hoai-Nghia Nguyen1, Hiromi Sesaki1
1Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Abstract:
Many tumors are associated with deficiency of the tumor suppressor, PTEN, a PIP3 phosphatase that turns off PIP3 signaling. The major site of PTEN action is the plasma membrane, where PIP3 is produced by PI3 kinases. However, the mechanism and functional importance of PTEN membrane recruitment are poorly defined. Using the heterologous expression system in which human PTEN is expressed in Dictyostelium discoideum, we defined the molecular mechanisms that regulate the membrane-binding site through inhibitory interactions with the phosphorylated C-terminal tail. In addition, we potentiated mechanisms that mediate PTEN membrane association and engineered an enhanced PTEN with increased tumor suppressor functions. Moreover, we identified a new class of cancer-associated PTEN mutations that are specifically defective in membrane association. In this review, we summarize recent advances in PTEN-membrane interactions and methods useful in addressing PTEN function.
Insights
Deficiency in the tumor suppressor PTEN (phosphatase and tensin homolog) is linked to cancer. This study clarifies PTEN
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- PTEN (phosphatase and tensin homolog) is a critical tumor suppressor frequently deficient in various cancers.
- PTEN counteracts PI3K/AKT signaling by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate (PIP3) primarily at the plasma membrane.
- The precise mechanisms governing PTEN's membrane recruitment and its functional significance remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms regulating PTEN's membrane association.
- To identify novel PTEN mutations associated with cancer that impair membrane recruitment.
- To engineer enhanced PTEN variants with improved tumor suppressor activity.
Main Methods:
- Utilized a heterologous expression system employing Dictyostelium discoideum to study human PTEN.
- Investigated inhibitory interactions involving the phosphorylated C-terminal tail of PTEN.
- Developed methods to potentiate PTEN membrane association and engineered enhanced PTEN variants.
Main Results:
- Defined molecular mechanisms controlling PTEN membrane binding, involving inhibitory interactions with its phosphorylated C-terminal tail.
- Successfully enhanced PTEN membrane association and created an engineered PTEN with augmented tumor suppressor functions.
- Identified a novel class of cancer-associated PTEN mutations specifically defective in membrane localization.
Conclusions:
- PTEN's tumor suppressor activity is intrinsically linked to its proper membrane recruitment.
- Understanding PTEN-membrane interactions provides insights into cancer development and offers therapeutic strategies.
- This work highlights the importance of PTEN localization and introduces new avenues for PTEN-based cancer therapies.
More Related Videos
Related Concept Videos
Single-pass Transmembrane Proteins
Membrane Proteins
Membrane Proteins
Introduction to Membrane Proteins
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
Mechanical Protein Functions

